Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia
BMC Cardiovascular Disorders volume 17, Article number: 218 (2017)
Data regarding the prevalence of metabolic syndrome (MetS) among hypertensive patients in Ethiopia is very scarce, and the nature and the burden of MetS among these patients has not been well investigated. Therefore, the aim of this study was to assess the pattern and risk factors of MetS in hypertensive patients.
A cross-sectional study was conducted at Hawassa University comprehensive specialized hospital from September 2015 to June 2016. Data on socio-demographic, clinical and anthropometric characteristics were collected from 238 hypertensive participants using WHO stepwise technique. Blood glucose and lipid profiles were determined after overnight fasting. Finally, MetS was defined according to National Cholesterol Education Program Adult Treatment Panel III Criteria.
The overall prevalence of MetS was 48.7% and urban dwellers had significantly higher prevalence of MetS (82.8%) compared to rural inhabitants (17.2%), p = 0.003. About 37.8%, 62.2%, 60.9% and 35.7% of the participants had abdominal obesity, elevated triglycerides, low HDL-c, and increased fasting blood glucose, respectively. In addition the mean HDL-c was significantly lower in MetS group compared to non-MetS group (39.4 vs.47.6), P < 0.0001. Age over 60 years, overweight, and obesity were associated risk factors of MetS. The adjusted odds ratio (95% CI) was 8.2 (1.1–62.4) for age over 60 years, 2.8 (1.4–5.9) for overweight and 10.7 (3.8–29.8) for obesity. Moreover monthly income of 1001–2000 Ethiopian birr, income ≥2001birr, a retirement pension, being married, divorced/widowed were also significantly associated risk factors of MetS, the adjusted odds ratio (95% CI) was 3.6 (1.1–12.5), 5.8 (1.5–22.3),5.3 (1.1–25.9),7.2 (1.4–35.9) and 16.4 (1.1–244.2), respectively.
Metabolic syndrome is highly prevalent among hypertensive patients and this may potentiate the risk of cardiovascular problems. Therefore, regular screening of patients for individual components of MetS is vital in order to avert/limit the risks before developing cardiovascular related morbidity and mortality.
The Cardiovascular diseases (CVD) account approximately 17 million deaths worldwide in a year; it is almost one third of the total deaths , and 9.4 million deaths every year due to complications of hypertension (HTN) globally . It is also supposed that HTN is accountable for a minimum of 45% death due to heart disease and 51% due to stroke . The prevalence of non-communicable chronic diseases (NCDs) is on rising worldwide in relation to high growth rate among populations in developing countries . Besides, NCDs are predicted to be highly increased in sub-Saharan Africa by 2030 [4, 5]. Of these NCDS, metabolic syndrome (MetS) is the one and it comprises a cluster of risk factors for developing CVD and which is characterized by abdominal obesity, increased blood pressure (BP), lipid derangements, hyperglycemia and insulin resistance [6,7,8]. The frequency of MetS in hypertensive individuals’ ranged from 30 to 40% . In addition the prevalence of MetS among Ethiopian working adults was 12.5% according to National Cholesterol Education Program Adult Treatment (NCEP-ATP) III criteria . However, the report from Northwest Ethiopia revealed that higher frequency of MetS (40.7%) in hypertensive patients .Furthermore, the use of some antihypertensive agents like diuretics or beta-adrenergic blocking drugs, may upsurge the insulin resistant state, and raises the tendency for the emerging type-II diabetes mellitus .
Data regarding MetS in hypertensive patients in Ethiopia is very scarce, the nature and the burden of MetS in these subjects has not been well investigated. Therefore, the aim of this study was to assess the pattern and associated factors of MetS among hypertensive individuals.
Study setting and study population
The study was conducted in Hawassa University comprehensive specialized Hospital, Southern Nations Nationalities and Peoples Region (SNNPR) from September 01/2015 to June 30/2016. Hawassa is the capital city of the region and located 275 km from Addis Ababa, which is the capital city of Ethiopia. This institution based cross sectional study was conducted in hypertensive patients. All hypertensive subjects age older than 18 years those who had a regular follow-up in the chronic disease clinic were eligible for the study. However, patients using lipid-altering drugs, women with confirmed pregnancy, previously diagnosed diabetic individuals, known cardiac and renal failures were excluded from the study.
Sample size and sampling technique
The sample size was calculated based on single population proportion formula using a 95% confidence interval (CI) and 81.3% prevalence of low HDL-c among hypertensive patients according to NCEP-ATP III .
where, P = proportion of low HDL-c, Zα/2 = Critical value at 95% level of confidence (Z = 1.96) d = Margin of error (5%). Based on the above formula with considering 5% non-response rate, the final sample size was calculated to be 244. To select participants from the study population, direct patient flow was checked for one week in the chronic diseases clinic and patients’ logbook was assessed additionally for its confirmation. Thus, the trend showed that the average weekly patient flow was approximately 70–80 cases for hypertensive patients. Finally, every fourth hypertensive patients were selected using systematic random sampling technique.
Assessments and measurements
Socio-demographic, anthropometric and other relevant clinical data of the study participants were collected by pre-tested structured questionnaires. Following this, trained nurse who were working at chronic diseases clinic recorded the physical/anthropometric examinations. Blood pressure (BP) of the patients was measured using a standard adult arm cuff of mercury type sphygmomanometer after a minimum of 5–10 min rest in the clinic. The precision of the measurment was maintained by using two readings within 2–3 min differences and finally the average blood pressure (BP) was taken and recorded to assess pressure(BP) status. In addition the third measurment was taken, when the two BP readings differed by 10 mmHg within a single individual, and finally the average of three readings was used. WHO stepwise approach was applied to collect data of weight, height and waist circumference . Individuals Weight and height was measured when they stood without shoes and wearing light garments. Body weight was measured using an electronic scale to the nearest 0.1 kg, and standing height was measured using a wall stadiometer to the nearest 0.1 cm. Moreover, body mass index (BMI) was calculated as the weight (in kilogram) divided by the square root of height (in meter) and it is classified according to international conventions: underweight (<18.5 Kg/m2), normal weight (18.5–24.9Kg/m2), overweight (25–29.9 kg/m2), and obesity (≥30 kg/m2) . Furthermore, waist circumference (WC) was measured at the umbilicus using a non-elastic tape to the nearest 0.1 cm with patients standing erect position after the end of a normal exhalation.
According to NCEP-ATP III guideline the intensity of physical activity explained as follows: moderate intensity of physical activities include: brisk walking for 30–40 min; 2-swimming-laps for 20 min; bicycling for pleasure or transportation around 5 miles in 30 min; Raking leaves for 30 min and other related activities. If an individual physical activity performance is lower than mentioned above, it is categorized under low intensity of physical activity . In addition, high intensity of physical activities include: walking after work for 30 min before getting in the car/ reaching home; walking up or down 1–2 trips of stairs instead of always taking the elevator; doing daily heavy house cleaning, push a stroller/take walks with your children; or other activities which require more energy .
A morning 4–5 ml blood was collected from each patient after overnight fast, and then serum was obtained for biochemical tests. Serum samples were analyzed for fasting blood sugar (FBS), high density lipoprotein cholesterol (HDL-c) and triglycerides (TGs) using A25™ BioSystem chemistry analyzer [BioSystems S.A. Costa Brava 30, Barcelona (Spain) (BioSystems™, Spain)]. TGs and FBS were analyzed using enzymatic colorimetric assay method, while a quantitative determination of HDL-c was done using direct homogeneous enzymatic assay technique. All reagents used for these analytes were from Germany (Human Gesellschaftfu¨r Biochemica und Diagnostica mBH).
Definition of metabolic syndrome
The presence of MetS was defined using the NCEP-ATP III guideline. The guideline illustrated that participants should have at least three of the following risk factors to be categorized under the group of MetS. This include abdominal obesity [defined as waist circumference (WC) >102 cm in men and >88 cm in women]; raised TGs level (≥150 mg/dl); low HDL-c (<40 mg/dl in men and <50 mg/dl in women); increased BP (systolic BP ≥130/diastolic BP ≥85 mmHg) and increased FBS (≥110 mg/dl) .
All questionnaires were checked visually, coded and entered into EPI INFO version 3.1 and exported to Statistical Package for Social Sciences (SPSS) Version 20 for analysis. Descriptive statistics were used to describe study population in relation to relevant variables. Chi-square and or fisher’s exact test was used for categorical variables. In addition, mean differences in quantitative continuous data of the study groups was evaluated by student’s t-test. The variation in the distribution of categorical variables in study groups was assessed using univariate and multivariate binary logistic regression. Furthermore, P-value <0.2 was used as a cut-off to comprise variables for multivariate binary logistic regression and finally results were considered as statistically significant when the p-value is < 5%.
Data quality control
Prior to actual data collection, the quality of data was assured by pre-testing of questionnaires in Sidama Zone “Bushulo” health center, which is 5 Km away from the study area. The questionnaires were evaluated for clarity and finally amendment was done after pre-testing. Socio-demographic, clinical and physical/anthropometric data of the study subjects was collected by trained nurses. In addition, the lab performance was managed daily through running quality control samples. If results fall outside established value, the run was repeated. Furthermore, the standard operating procedures manual was used to perform all the laboratory procedures.
Socio-demographic and metabolic characteristics of the study subjects
A total of 238 hypertensive patients approached, six of them (2.5%) refused to take part in the study. Of whom 105 (44.1%) men and 133 (55.9%) were women. The mean (±SD) age of the study participants was 53.2 (14.5) years. The prevalence of Mets was 116(48.7%) and the mean age was significantly higher among MetS group when compared to non-MetS group [55.5(13.7) vs.51 (14.9); p = 0.02], respectively. About 73.9%, 89.9%, 36.6%, 35.3% of the study participants were urban inhabitants, married, educationally primary level and housewives, respectively. Besides urban dwellers had significantly higher MetS when compared to rural inhabitants (82.8% vs. 17.2%), p = 0.003, respectively. Around 11.8% had a vigorous intensity working habits in their day-to-day activities that include farming, walking long distances on foot and doing tough activities. Furthermore, 26.9% of the participants had experiences of performing physical exercises regularly and 1.7% had a history of alcoholism (Table 1).
Clinical, biochemical and other features of the study subjects
About 50(21%) of the study participants had a family history of chronic illnesses (diabetes mellitus, 7.6% and hypertension, 13.4%). Majority (95%) of the participants had been using at least one anti-hypertensive agents. The range of ant-hypertensives treatment duration was two months to forty years, and 9.2% of patients were on treatment for more than ten years. In addition the mean systolic BP, diastolic BP, FBS, TGs and BMI were significantly higher in MetS group when compared to non-MetS group (p < 0.0001 for all). However, the mean HDL-c was significantly lower in MetS group when compared to non-MetS group (39.4 vs. 47.6), respectively, p < 0.0001 (Table 2).
Features of metabolic syndrome and its components
MetS was higher in women when compared to men (54.1% vs. 41.9%; p = 0.06), respectively. The prevalence of abdominal obesity, raised FBS, raised TGs and low HDL-c were 37.8%, 35.7%, 62.2% and 60.9%, respectively. In addition the prevalence of low HDL-c and abdominal obesity were significantly higher in women compared to men (69.9% vs. 49.5%; p = 0.001) and (18.1% vs. 53.4%; p < 0.0001), respectively. In contrast BP ≥130 mmHg was significantly higher in men (78.1%) compared to women (64.7%), p = 0.02 (Table 3). Furthermore, three or more abnormal components of MetS within a single individual were higher in urban dwellers compared to rural one (Fig. 1).
Factors associated with the presence of metabolic syndrome
Based on NCEP-ATP III criteria: being an urban, the crude odds ratio [COR (95% CI):2.3 (1.25–4.2); p = 0.007] and being hypertensive for more than 10 years [COR (95% CI): 2.5(1.1–5.7); p = 0.02] were associated with MetS. In addition, being a housewife [COR (95% CI): 3.36 (1.4–7.9); p = 0.006], a retirement pension [COR (95% CI):4.1(1.25–13.5); p = 0.02], married [COR (95% CI):2.5(1.1–7.4); p = 0.03], and divorced/widowed (95% CI):13(1.2–140.7); p = 0.02] were also associated with MetS. However multivariate analysis was maintained for possible confounding factors, being married [AOR (95% CI):7.2(1.4–35.9); p = 0.02], divorced/widowed [AOR (95% CI):16.4(1.1–244.2); p = 0.04], and a retirement pension [AOR (95% CI):5.3(1.1–25.9); p = 0.04] were significantly and positively associated risk factors of MetS. Furthermore, monthly income rates, age over 60 years, overweight, and obesity were also associated risk factors of MetS (Table 4).
MetS is a multifaceted disorder, which is responsible for a whole of cardiovascular risks and usually associated with central adiposity, dyslipidemia and insulin resistance. The overall prevalence of MetS in the study was 48.7% according to NCEP-ATP III criteria and the proportion was higher in women compared to men. Urban dwellers had significantly higher MetS when compared to rural inhabitants. In addition, abdominal obesity and low HDL-c were significantly higher in women when compared to men. Furthermore, marital status, on retirement pension, overweight and obesity were significantly associated risk factors of MetS.
A number of international studies highlight different prevalence of MetS in adult hypertensive patients like: Nigeria (42.5%), India (63.5%), Brazil (82.4%), and Iran (51.6%) [16,17,18,19], respectively. In the present study, the prevalence of MetS was 48.7% and the rate was comparable with the study report from Nigeria, which was 45.6% . However, the finding was higher than the prevalence reported from Northwest Ethiopia and other African settings, which was 40.7%, 13% and 31.2% [11, 21, 22], respectively. This indicates metabolic complications of hypertensive patients bring in them to future risk of cardiovascular diseases and diabetes. The possible explanations for the variation could be genetic disparities between populations, ethnicity, socio-demographic characteristics, lifestyle, duration of hypertension and experiences of anti-hypertensive treatment. We found that the prevalence of MetS in urban inhabitants was 82.8%. This prevalence rate is higher than the report from several studies like: 35.5% in Northwest Ethiopia , 33.2% in Wuhan, China  and 27.4% in Northeast China . And this suggest that a potential risk for the development of cardiovascular diseases in a significant proportion of hypertensive patients in the near future especially those patients who were living in urban. Therefore, the condition calls for a critical attention to create awareness for individuals living in urban situation concerning how to modify their life style in order to limit/prevent MetS risks.
The prevalence of MetS among hypertensive women was 54.1%. It is comparable with the prevalence reported from Nigeria, 54%  and other two studies of China, 52.3%  and 56.4% . However, it is higher than the prevalence reported from Abuja state in the Nigeria, which was 38.9% .The differences may be attributed to the reality that only newly identified hypertensive individuals were involved in the Nigerian study. In addition, the proportion of WC was significantly higher in women when compared to men. This in line with the prevalence reported from Nigeria  and China .
We found that the prevalence of lipid profile derangement (low HDL-c) among women was 69.9%. However, high prevalence rate was reported from Northwest Ethiopia, which was 85.4% . The differences in proportion may be due to the impact of age on HDL-c, as comparatively high rate (46.5%) of the study women were found to be in menopause age (>50 years) in the depicted study. Moreover, different studies reported that female sex was significantly associated risk factor of MetS [11, 12, 25]. However, this is not in line with our study finding.
We found that BMI of ≥25 (i.e. overweight and obesity) were significantly associated with the prevalence of MetS. Likewise, several studies reported that the BMI is a quantitative predictor of metabolic disturbances [12, 26]. Duration since the diagnosis of hypertension is associated with MetS . In contrary, our study showed that no association between the duration of hypertension and MetS after maintaining for possible confounding factors in multivariate analysis.
Monthly income rate was significantly associated with MetS. This finding is similar with the study report from China . This reflects the effect of income on MetS, however this relationship may be vary from developing country to developed one . In line with the reports from Kuwait  and Nigeria , we found that age was significantly associated risk factor of MetS. In addition several studies reported that performing moderate to vigorous intensity of physical exercise decreases the developing of MetS risks [25, 29]. Concordantly we found that the low prevalence rate of MetS among patients who had an experiences of performing moderate to vigorous intensity of physical activity. Furthermore, our study indicated that marital status was significantly associated factor of MetS. This finding is similar with the reports from different studies [30,31,32,33]. Satisfaction for most individuals in marriage-like relationship might be a consequence for some abnormal components of MetS, and also in support of our finding: the prevalence rate of obesity (a component of MetS) was higher among married subjects compared to non-married one according to Rguibi et al. report .
Limitation of the study
First, our study was a cross-sectional suggesting that it cannot provide adequate evidence of causality regarding MetS and its risk factors. Second, we used only one classification was used to evaluate the frequency of MetS; a different prevalence rate might be detected if other MetS criteria like the world health organization (WHO) and or, international diabetes federation (IDF) were used. Third, our study included only hypertensive patients and that was not wide-ranged. Fourth, we did not assess the nutritional status of the individuals because of its difficulties in our situations and we have not analyzed the data of cigarette smoking because we got only one individual who had a history of smoking. Regardless of the depicted limitations, this study ultimately adds supportive information on MetS in a limited data situation of sub-Saharan Africa, mainly in Ethiopia including the study area.
Metabolic syndrome is highly prevalent among hypertensive subjects. Marital status, BMI, income rate and age were found to have a significant association with MetS. This indicates the majority of hypertensive individuals are at a high risk of developing MetS. Therefore, physicians/clinicians should give attention for the problem and adhere to NCEP-ATP III guideline to diagnose patients, to manage risk conditions and to treat individuals with such metabolic complications . Furthermore, we recommend longitudinal studies to address others unexplained predictors of MetS, and to assess concealed burden of MetS in hypertensive patients at a national level.
adjusted odds ratio
body mass index
- C I:
crude odds ratio
fasting blood sugar
High density lipoprotein-cholesterol
National Cholesterol Education Program-Adult Treatment Panel
Statistical package for social sciences
World Health Organization
Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD. 2013;1:1–2.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Study2010. Lancet. 2012;380:2224–60.
Murray JL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet. 1997;349:1498–504.
Mathers CD, Loncar D. projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291:2616–22.
Lu B, Yang Y, Song X, Dong X, Zhang Z, Zhou L, et al. An evaluation of the international diabetes federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metab. 2006;55:1088–96.
Muhammad S, Sani MU, Okeahialam BN. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians. Ann Afr Med. 2013;12:24–8.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150–9.
Marchi-Alves LM, Rigotti AR, Nogueira MS, Cesarino CB, de Godoy S. Metabolic syndrome components in arterial hypertension. Rev Esc Enferm USP. 2012;46:1348–53.
Tran A, Gelaye B, Girma B, Lemma S, Berhane Y, Bekele T, et al. Prevalence of Metabolic Syndrome among Working Adults in Ethiopia. Int J Hypertens. 2011; doi:10.4061/2011/193719.
Tachebele B, Abebe M, Addis Z, Mesfin N. Metabolic syndrome among hypertensivepatients at University of Gondar Hospital, North West Ethiopia. BMC Cardiovasc Disord. 2014;14:177.
Hsu CN, Chen YC, Wang TD. Prevalence and characteristics of the metabolic syndrome in Chinese hypertensive patients: a hospital-based observation. Acta Cardiol Sin. 2005;21:89–97.
World Health Organization (WHO): Chronic diseases and health promotion: Stepwise approach to surveillance (STEPS). 2010. http://www.who.int/chp/steps/manual/en/.
Expert panel on the Identification. Evaluation, and treatment of overweight and obesity in adults: executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855–67.
National Cholesterol Education Program (NCEP). The third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–421.
Akintunde AA, Ayodele OE, Akinwusi PO, Opadijo GO. Metabolic syndrome: comparison of occurrence using three definitions in hypertensive patients. Clin Med Res. 2011;9:26–31.
Thakur S, Raina S, Thakur S, Negi PC, Verma BS. Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India. Indian J Endocrinol Metab. 2013;17:723–6.
Kelishadi R, Derakhshan R, Sabet B, Sarraf-Zadegan N, Kahbazi M, Sadri GH, et al. The metabolic syndrome in hypertensive and normotensive subjects: the Isfahan healthy heart Programme. Ann Acad Med Singap. 2005;34:243–9.
Bulhões K, Araújo L. Metabolic syndrome in hypertensive patients: correlation between anthropometric data and laboratory findings. Diabetes Care. 2007;30:1624–6.
Ogbu ISI, Ugwuja EI. Metabolic syndrome in hypertensive Nigerians: risk factor analysis. IOSR J Pharm BiolSci. 2012;4:28–32.
Ojji DB, Ajayi SO, Mamven MH, Alabi P. Prevalence of metabolic syndrome among hypertensive patients in Abuja, Nigeria. Ethn Dis. 2012;22:1–4.
Osuji CU, Omejua EG. Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients. Indian J Endocrinol Metab. 2012;16:104–9.
Chen M, He M, Min X, Pan A, Zhang X, Yao P, et al. Different physical activity subtypes and risk of metabolic syndrome in middle-aged and older Chinese people. PLoS One. 2013;8:e53258.
Song QB, ZhaoY LYQ, Zhang J, Xin SJ, Dong GH. sex difference in the prevalence of metabolic syndrome and cardiovascular related risk factors in urban adults from 33 communities of China: the CHPSNE study. Diab Vasc Dis Res. 2015;12:189–98.
Yu S, Guo X, Yang H, Zheng L, Sun Y. Metabolic syndrome in hypertensive adults from rural Northeast China: an update. BMC Public Health. 2015;15:247.
Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, et al. Metabolic syndrome and its correlated factors in an urban population in south west of Iran. J Diab Metab Disord. 2013;12:11.
Shariff ZM, Sulaiman N, Jalil RA, Yen WC, Yaw YH, Taib MN, et al. Food insecurity and the metabolic syndrome among women from low-income communities in Malaysia. Asia Pac J Clin Nutr. 2014;23:138–47.
Sorkhou EI, Al-Qallaf B, Al-Namash HA, Ben-Nakhi A, Al-Batish MM, Habiba SA. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med PrincPract. 2004;13:39–42.
Bergstrom G, Behre C, Schmidt C. Increased leisure-time physical activity isassociated with lower prevalence of the metabolic syndrome in 64-year oldwomen with impaired glucose tolerance. Angiol. 2012;63:297–301.
Erem C, Hacihasanoglu A, Deger O, Topbaş M, Hosver I, Ersoz HO, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults. Trabzon MetS study. Endocrine. 2008;33:9–20.
Sirdah MM, Al Laham NA, Abu Ghali AS. Prevalence of metabolic syndrome and associated socioeconomic and demographic factors among palestinian adults (20–65 years) at the Gaza strip. Diabetes Metab Syndr. 2011;5:93–7.
Al-Daghri NM, Alkharfy KM, Al-Attas OS, Khan N, Alfawaz HA, Alghanim SA, et al. Gender dependent associations between socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population. BMC Cardiovasc Disord. 2014;14:51.
Delavar MA, Lye M-S, Khor GL, Hanachi P, Hassan ST. Prevalence of metabolic syndrome among middle aged women in Babol, Iran. Southeast Asian J Trop Med Public Health. 2009;40:612.
Rguibi M, Belahsen R. Overweight and obesity among urban Sahraoui women of South Morocco. Ethn Dis. 2004;14:542–7.
We want to acknowledge the nurses who were working in the chronic disease clinic of Hawassa University comprehensive specialized hospital, Dr., Eyob Bekele and Abebe Kifle for their immeasurable support during data collection. Further our gratefulness is also extended to the hypertensive patients for their eagerly involvement in the study.
This study was financially supported by Hawassa University Research and Technology Transfer Office.
Availability of data and materials
The dataset of this article is accessible on reasonable request from the corresponding author.
Ethics approval and consent to participate
This study was approved by the institutional review board (IRB) of Hawassa University, College of Medicine and Health Sciences. All the study participants were well informed about the protocol of the study and written informed consent was obtained from all participants. In addition, the privacy of personal information was strictly preserved.
Consent for publication
The authors announce that they have no any competing welfares.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tadewos, A., Egeno, T. & Amsalu, A. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia. BMC Cardiovasc Disord 17, 218 (2017). https://doi.org/10.1186/s12872-017-0648-5